Archives
-
University of Sussex and o2h Ventures Announce Creation and Investment in Stingray Bio, a Company for New Oncology Drugs Targeting the LMTK3 Kinase Pathway 08 April, 2021
-
The o2h human health S/EIS flagship fund – Fully Deployed 01 April, 2021
-
o2h Ventures invests into SomaServe’s successful Series A funding round 31 March, 2021
-
o2h Ventures invests in PhoreMost Series B financing 23 March, 2021
-
o2h Human Health EIS Fund leads an investment into Kuano, using quantum and AI to accelerate the development of new medicine. 25 February, 2021
-
o2h ventures backed Small Pharma receives approval for world’s first DMT for depression clinical trial 22 February, 2021
-
o2h Ventures invests into the UCL spin out company SomaServe. 22 February, 2021
-
o2h ventures – making waves in knowledge intensive and SEIS investing 21 December, 2020
-
Knowledge intensive investing… a new investment era 09 December, 2020
invest in the growth potential of UK life science & AI